Mass spectrometry analysis of nucleosides and nucleotides

Mass Spectrometry Reviews

Volumn 33, Issue 4, 2014, Pages 302-331

  Dudley, Ed ^a   Bond, Liz ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

DNA adducts; modified nucleosides; nucleosides; nucleotides

Indexed keywords

NUCLEIC ACIDS; NUCLEOTIDES;

CHROMATOGRAPHIC TECHNIQUES; DNA ADDUCTS; MASS SPECTROMETRY ANALYSIS; MODIFIED NUCLEOSIDES; NUCLEOBASES; NUCLEOSIDES;

MASS SPECTROMETRY;

DNA ADDUCT; NUCLEOSIDE; NUCLEOTIDE; TRANSFER RNA;

ANALYSIS; ANIMAL; CHEMICAL STRUCTURE; COMPUTER SYSTEM; DNA ADDUCT; DNA METHYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PROCEDURES; RNA PROCESSING; URINE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; COMPUTER SYSTEMS; DNA ADDUCTS; DNA METHYLATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MASS SPECTROMETRY; MOLECULAR STRUCTURE; NUCLEOSIDES; NUCLEOTIDES; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, TRANSFER;

EID: 84902360951     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.21388     Document Type: Article

References (214)

1. Addepalli B, Limbach PA,. 2011. Mass spectrometry-based quantification of pseudouridine in RNA. Am Soc Mass Spectrom 22: 1363-1372.
2. Alexandrov A, Chernyakov I, Gu W, Hiley SL, Hughes TR, Grayhack EJ, Phizicky EM,. 2006. Rapid tRNA decay can result from lack of nonessential modifications. Mol Cell 21 (1): 87-96.
3. Andersen TE, Kirpekar F, Haselmann KF,. 2006. RNA fragmentation in MALDI mass spectrometry studied by H/D-exchange: Mechanisms of general applicability to nucleic acids. J Am Soc Mass Spectrom 17: 1353-1368.
4. Anichina J, Zhoa Y, Hrudey SE, Schreiber A, Li XF,. 2011. Electrospray ionisation tandem mass spectrometry analysis of the reactivity of structurally related bromo-methyl-benzoquinones toward oligonucleotides. Anal Chem 83 (21): 8145-8151.
5. Azzari C, la Marca G, Resti M,. 2011. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: A reliable and inexpensive method using tandem mass spectrometry. J Allergy Clin Immunol 127 (6): 1394-1399.
6. Balbo S, Meng L, Bliss RL, Jensen JA, Hatsukami DK, Hecht SS,. 2012. Time course of DANN adduct formation in peripheral blood granulocytes and lymphocytes after drinking alcohol. Mutagenesis 27: 485-490.
7. Bartholomä MD, Vortherms AR, Hillier S, Ploier B, Joyal J, Babich J, Doyle RP, Zubieta J,. 2010. Synthesis, cytotoxicity, and insight into the mode of action of Re(CO)3 thymidine complexes. ChemMedChem 5 (9): 1513-1529.
8. Begemann P, Boysen G, Georgieva NI, Sangaiah R, Koshlap KM, Koc H, Zhang D, Golding BT, Gold A, Swenberg JA,. 2011. Identification and characterisation of 2′-deoxyadenosine adducts formed by isoprene monoepoxides in vitro. Chem Res Toxicol 24: 1048-1061.
9. Behm-Ansmant I, Helm M, Motorin Y,. 2011. Use of specific chemical reagents for detection of modified nucleotides in RNA. J Nucleic Acids 1-17.
10. Ben-Avraham D, Muzumdar RH, Atzmon G,. 2012. Epigenetic genome-wide association methylation in aging and longevity. Epigenomics 4 (5): 503-509.
11. Bond A, Dudley E, Lemière F, Tuytten R, El-Sharkawi S, Brenton AG, Esmans EL, Newton RP,. 2006. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry. Rapid Commun Mass Spectrom 20 (2): 137-150.
12. Bond AE, Dudley E, Tuytten R, Lemière F, Smith CJ, Esmans EL, Newton RP,. 2007. Mass spectrometric identification of Rab23 phosphorylation as a response to challenge by cytidine 3′,5′-cyclic monophosphate in mouse brain. Rapid Commun Mass Spectrom 21 (16): 2685-2692.
13. Bond AE, Ding S, Williams CM, Newton RP, Dudley E,. 2011. Mass spectrometric fragmentation behaviour of cAMP analogues. Int J Mass Spectrom 304 (2-3): 130-139.
14. Borek E, Baliga BS, Gehrke CW, Ku CW, Belman OS, Troll W, Waalkes TP,. 1977. High turnover rate in tumour tissue. Cancer Res 37: 3362-3366.
15. Brachwitz H, Thomas Y, Bergmann J, Langen P, Berdel WE,. 1997. New nucleoside-5′-alkylphosphonophosphates and related compounds containing 2′-deoxycytidine, thymidine and adenosine as nucleoside component. Syntheses and their effects on tumor cell growth in vitro. Chem Phys Lipids 87 (1): 31-39.
16. Brown K,. 2012. Methods for the detection of DNA adducts. Methods Mol Biol 817: 207-230.
17. Buck M, Connick M, Ames BN,. 1983. Complete analysis of tRNA modified nucleosides by HPLC: The 29 modified nucleosides of S. typhimurium and E. coli tRNA. Anal Biochem 129: 1-13.
18. Bullinger D, Neubauer H, Fehm T, Laufer S, Gleiter CH, Kammerer B,. 2007. Metabolic signature of breast cancer cell line MCF-7: Profiling of modified nucleosides via LC-IT MS coupling. BMC Biochem 8: 25.
19. Bullinger D, Fux R, Nicholson G, Plontke S, Belka C, Laufer S, Gleiter CH, Kammerer B,. 2008. Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis. J Am Soc Mass Spectrom 19 (10): 500-513.
20. Bushman LR, Kiser JJ, Rower JE, Klein B, Zheng JH, Ray ML, Anderson PL,. 2011. Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. J Pharm Biomed Anal 56 (2): 390-401.
21. Cantara WA, Crain PF, Rozenski J, McCloskey JA, Harris KA, Zhang X, Vendeix FA, Fabris D, Agris PF,. 2011. The RNA modification database, RNAMDB: 2011 update. Nucleic Acids Res 39: D195-D201.
22. Cao H, Wang Y,. 2006. Collisionally activated dissociation of protonated 2′-deoxycytidine, 2′-deoxyuridine, and their oxidatively damaged derivatives. J Am Soc Mass Spectrom 10: 1335-1341.
23. Carrier EJ, Amarnath V, Oates JA, Boutaud O,. 2009. Characterisation of covalent adducts of nucleosides and DNA formed by reaction with levuglandin. Biochemistry 48 (45): 10775-10781.
24. Casale GP, Singha M, Bhattacharya S, RamaNathan R, Roberts KP, Barbacci DC, Zhao J, Jankowiak R, Gross ML, Cavalieri EL, Small GJ, Rennard SI, Mumford JL, Shen M,. 2001. Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem Res Toxicol 14: 192-201.
25. 6-dimethyladenosine in transfer RNA from Mycobacterium bovis Bacille Calmette-Guerin. Molecules 16: 5168-5181.
26. Chen HJ, Kao CF,. 2007. Effect of gender and cigarette smoking on urinary excretion of etheno DNA adducts in humans measured by isotope dilution gas chromatography/mass spectrometry. Toxicol Lett 169 (1): 72-81.
27. Chen HJ, Lin WP,. 2011. Quantitative analysis of multiple exocyclic DNA adducts in human salivary DNA by stable isotope dilution nanoflow liquid chromatography-nanospray ionisation tandem mass spectrometry. Anal Chem 83: 8543-8551.
28. Chen HJ, Chiang LC, Tseng MC, Zhang LL, Ni J, Chung FL,. 1999. Detection and quantification of 1,N(6)-ethenoadenine in human placental DNA by mass spectrometry. Chem Res Toxicol 12 (12): 1119-1126.
29. Chen XJ, Yang FQ, Wang YT, Li SP,. 2010. CE and CEC of nucleosides and nucleotides in food materials. Electrophoresis 31 (13): 2092-2105.
30. Chen C, Huang B, Anderson JT, Bystrom AS,. 2011. Unexpected accumulation of ncm5 U and ncm5 s 2 U in a trm9 mutant suggests an additional step in the synthesis of mcm5 U and mcm5 s 2 U. PLoS ONE 6: e20783.
31. Chen HJ, Wang YC, Lin WP,. 2012. Analysis of ethylated thymidine adducts in human leukocyte DNA by stable isotope dilution nanoflow liquid chromatography-nanospray ionization tandem mass spectrometry. Anal Chem 84: 2521-2527.
32. Chheda GB, Patrzyc HB, Tworek HA, Dutta SP,. 1999. Isolation and characterization of 5-carbamoylmethyluridine and 5-carbamoylmethyl-2-thiouridine from human urine. Nucleosides Nucleotides 18 (10): 2155-2173.
33. Cho SH, Choi MH, Lee WY, Chung BC,. 2009. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. Clin Biochem 42 (6): 540-543.
34. Compagnone D, Curini R, D'Ascenzo G, Del Carlo M, Montesano C, Napoletano S, Sergi M,. 2011. Neutral loss and precursor ion scan tandem mass spectrometry for study of activated benzopirene-DNA adducts. Anal Bioanal Chem 401: 1983-1991.
35. Coombs CC, Limbach PA,. 2010. Electrospray ionisation mass spectrometry for the direct analysis of modified nucleosides in small RNAs., Banoub JH, Limbach PA,. editors. Mass spectrometry of nucleoside and nucleic acids. Florida, FL: CRC Press, Taylor & Francis Group LLR. pp. 423-430.
36. Crain PF,. 1990. Preparation and enzymatic hydrolysis of DNA and RNA for mass spectrometry. In:, McCloskey JA, editor. Nucleic acid constituents. Methods in enzymology. Vol. 193. New York, CA: Academic Press, Inc. pp. 782-790.
37. Cui Z, Theruvathu JA, Farrel A, Burdzy A, Sowers LC,. 2008. Characterisation of synthetic oligonucleotides containing biologically important modified bases by MALDI-ToF MS. Ana Biochem 379: 196-207.
38. Curtis M, Minier MA, Chitranshi P, Sparkman OD, Jones PR, Xue L,. 2010. Direct analysis in real time (DART) mass spectrometry of nucleotides and nucleosides: Elucidation of a novel fragment [C5H5O]+ and its in-source adducts. J Am Soc Mass Spectrom 21 (8): 1371-1381.
39. Czerwoniec A, Dunin-Horkawicz S, Purta E, Kaminska KH, Kasprzak JM, Bujnicki JM, Grosjean H, Rother K,. 2009. MODOMICS: A database of RNA modification pathways. 2008 update. Nucleic Acids Res 37: D118-D121.
40. Da Costa GG, Churchwell MI, Hamilton LP, Von Tungeln LS, Beland FA, Marques MM, Doerge DR,. 2003. DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem Res Toxicol 16: 1328-1337.
41. De Vijlder T, Boschmans J, Witters E, Lemière F,. 2011. Study on the loss of nucleoside mono-, di- and triphosphates and phosphorylated peptides to a metal-free LC-MS hardware. Int J Mass Spec 304 (2-3): 83-90.
42. Deaton AM, Bird A,. 2011. CpG islands and the regulation of transcription. Genes Dev 25: 1010-1022.
43. Ding S, Bond AE, Lemière F, Tuytten R, Esmans EL, Brenton AG, Dudley E, Newton RP,. 2008. Online immobilized metal affinity chromatography/mass spectrometric analysis of changes elicited by cCMP in the murine brain phosphoproteome. Rapid Commun Mass Spectrom 22 (24): 4129-4138.
44. Doak SH, Brüsehafer K, Dudley E, Quick E, Johnson G, Newton RP, Jenkins GJ,. 2008. No-observed effect levels are associated with up-regulation of MGMT following MMS exposure. Mutat Res 648 (1-2): 9-14.
45. Docherty SJ, Davis OSP, Haworth CMA, Plomin R, Mill J,. 2010. DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA. Methods 52 (3): 255-258.
46. Doerge DR, Yi P, Churchwell MI, Preece SW, Langridge J, Fu PP,. 1998. Mass spectrometric analysis of 2-deoxyribonucleoside and 2′- deoxyribonucleotide adducts with aldehydes derived from lipid peroxidation. Rapid Commun Mass Spectrom 12 (22): 1665-1672.
47. Dudley E, El-Shakawi S, Games DE, Newton RP,. 2000a. Development of a purification procedure for the isolation of nucleosides from urine prior to mass spectrometric analysis. Nucleosides Nucleotides Nucleic Acids 19 (3): 545-558.
48. Dudley E, El-Sharkawi S, Games DE, Newton RP,. 2000b. Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/ electrospray mass spectrometry. Rapid Commun Mass Spectrom 14 (14): 1200-1207.
49. Dudley E, Lemiere F, Van Dongen W, Esmans E, El-Sharkawi AM, Games DE, Brenton AG, Newton RP,. 2003a. Urinary modified nucleosides as tumor markers. Nucleosides Nucleotides Nucleic Acids 22 (5-8): 987-989.
50. Dudley E, Lemiere F, Van Dongen W, Langridge JI, El-Sharkawi S, Games DE, Esmans EL, Newton RP,. 2003b. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides. Rapid Commun Mass Spectrom 15 (18): 1701-1707.
51. Dudley E, Lemiere F, Van Dongen W, Langridge JI, El-Sharkawi S, Games DE, Esmans EL, Newton RP,. 2003c. Analysis of urinary nucleosides. III. Identification of 5′-deoxycytidine in urine of a patient with head and neck cancer. Rapid Commun Mass Spectrom 17 (11): 1132-1136.
52. Dudley E, Lemière F, Van Dongen W, Tuytten R, El-Sharkawi S, Brenton AG, Esmans EL, Newton RP,. 2004. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/ electrospray mass spectrometry. Rapid Commun Mass Spectrom 18 (22): 2730-2738.
53. Dudley E, Tuytten R, Bond A, Lemière F, Brenton AG, Esmans EL, Newton RP,. 2005. Study of the mass spectrometric fragmentation of pseudouridine: Comparison of fragmentation data obtained by matrix-assisted laser desorption/ionisation post-source decay, electrospray ion trap multistage mass spectrometry, and by a method utilising electrospray quadrupole time-of-flight tandem mass spectrometry and in-source fragmentation. Rapid Commun Mass Spectrom 19 (21): 3075-3085.
54. Durairaj A, Limbach PA,. 2008. Improving CMC-derivatisation of pseudouridine in RNA for mass spectrometric detection. Anal Chim Acta 612: 173-181.
55. Esmans EL, Geboes P, Luyten Y, Alderweireldt FC,. 1985. Direct liquid introduction LC/MS microbore experiments for the analysis of nucleoside material present in human urine. Biomed Mass Spectrom 12 (5): 241-245.
56. Esther CR, Jr., Lazaar AL, Bordonali E, Qaqish B, Boucher RC,. 2011. Elevated airway purines in COPD. Chest 140 (4): 954-960.
57. Farand J, Gosselin F,. 2009. De novo sequence determination of modified oligonucleotides. Anal Chem 81: 3723-3730.
58. Farmer PB, Brown K, Tompkins E, Emms VL, Jones DJ, Singh R, Phillips DH,. 2005. DNA adducts: Mass spectrometry methods and future prospects. Toxicol Appl Pharmacol 207: 293-301.
59. Farrand J, Beverly M,. 2008. Sequence confirmation of modified oligonucleotides using chemical degradation, electrospray ionisation, time-of-flight, and tandem mass spectrometry. Anal Chem 80: 7414-7421.
60. Flosadõttir HD, Jõnsson H, Sigurdsson ST, Ingõlfsson O,. 2011. Experimental and theoretical study of the metastable decay of negatively charged nucleosides in the gas phase. Phys Chem Chem Phys 13 (33): 15283-15290.
61. Frańska M,. 2010. Cytidine-Ag+-purine base complexes as studied by electrospray ionization mass spectrometry. Eur J Mass Spectrom 16 (5): 587-594.
62. Frickenschmidt A, Frohlich H, Bullinger D, Zell A, Laufer S, Gleiter CH, Liebich H, Kammerer B,. 2008. Metabonomics in cancer diagnosis: Mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Biomarkers 13 (4): 435-449.
63. Gehrig S, Eberle M-E, Botschen F, Rimbach K, Eberle F, Eigenbrod T, Kaiser S, Holmes WM, Erdmann VA, Speinzl M, Bec G, Keith G, Dalpke AH, Helm M,. 2011. Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity. J Exp Med 209: 225-233.
64. Gehrke CW, Kuo KC,. 1989. Ribonucleoside analysis by reversed-phase high-performance liquid chromatography. J Chromatogr 471: 3-36.
65. Giessing AMB, Kirpekar F,. 2012. Mass spectrometry in the biology of RNA and its modifications. J Proteomics 75 (12): 3434-3449.
66. n based strategy for characterization of modified nucleosides using reduced porous graphitic carbon as a stationary phase. J Am Soc Mass Spectrom 22 (7): 1242-1251.
67. Godfrey AR, Williams CM, Dudley E, Newton RP, Willshaw P, Mikhail A, Bastin L, Brenton AG,. 2009. Investigation of uremic analytes in hemodialysate and their structural elucidation from accurate mass maps generated by a multi-dimensional liquid chromatography/mass spectrometry approach. Rapid Commun Mass Spectrom 23 (19): 3194-3204.
68. Gregson JM, McCloskey JA,. 1997. Collision-induced dissociation of protonated guanine. Int J Mass Spec Ion Proc 165-166: 475-485.
69. Gu D, Turesky RJ, Tao Y, Langouët SA, Nauwelaërs GC, Yuan JM, Yee D, Yu MC,. 2012. DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry. Carcinogenesis 33 (1): 124-130.
70. Guérard F, Pétriacq P, Gakière B, Tcherkez G,. 2011. Liquid chromatography/time-of-flight mass spectrometry for the analysis of plant samples: A method for simultaneous screening of common cofactors or nucleotides and application to an engineered plant line. Plant Physiol Biochem 49 (10): 1117-1125.
71. Guo S, Duan JA, Tang YP, Zhu ZH, Qian YF, Yang NY, Shang EX, Qian DW,. 2010. Characterization of nucleosides and nucleobases in fruits of Ziziphus jujuba by UPLC-DAD-MS. J Agric Food Chem 58 (19): 10774-10780.
72. Guo L, Wu H, Yue H, Lin S, Lai Y, Cai Z,. 2011. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879: 153-158.
73. Guza R, Kotandeniya D, Murphy K, Dissanayake T, Lin C, Giambasu GM, Lad RR, Wojciechowski F, Amin S, Sturla SJ, Hudson RH, York DM, Jankowiak R, Jones R, Tretyakova NY,. 2011. Influence of C-5 substituted cytosine and related nucleoside analogs on the formation of benzo[a]pyrene diol epoxide-dG adducts at CG base pairs of DNA. Nucleic Acids Res 39 (9): 3988-4006.
74. Hakkinen MR, Laine JE, Juvonen RO, Auriola S, Hayrinen J, Pasanen M,. 2011. 2′-Deoxyguanosine as a surrogate trapping agent for DNA reactive drug metabolites. Toxicol Lett 207: 34-41.
75. Havelund JF, Giessing AMB, Hansen T, Rasmussen A, Scott LG, Kirpekar F,. 2011. Identification of 5-hydroxycytidine at position 2501 concludes characterisation of modified nucleotides in E. coli 23S rRNA. J Mol Biol 411: 529-536.
76. Helm M,. 2006. Post-transcriptional nucleotide modification and alternative folding of RNA. Nucleic Acids Res 34: 721.
77. Henneges C, Bullinger D, Fux R, Friese N, Seeger H, Neubauer H, Laufer S, Gleiter CH, Schwab M, Zell A, Kammerer B,. 2009. Prediction of breast cancer by profiling of urinary RNA metabolites using support vector machine-based feature selection. BMC Cancer 9: 104.
78. Himmelstein MW, Boogaard PJ, Cadet J, Farmer PB, Kim JH, Martin EA, Persaud R, Shuker DE,. 2009. Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol 39 (8): 679-694.
79. Hofmann U, Heinkele G, Angelberger S, Schaeffeler E, Lichtenberger C, Jaeger S, Reinisch W, Schwab M,. 2012. Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry. Anal Chem 84 (3): 1294-1301.
80. Holstege A, Pauw M, Häring R, Kirchner R, Pausch J, Gerok W,. 1986. Value of increased urinary excretion of modified nucleosides as tumor markers in colon cancer. Verh Dtsch Ges Inn Med 92: 114-120.
81. Hsu WY, Chen WT, Lin WD, Tsai FJ, Tsai Y, Lin CT, Lo WY, Jeng LB, Lai CC,. 2009. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 402 (1-2): 31-37.
82. Hsu WY, Lin WD, Tsai Y, Lin CT, Wang HC, Jeng LB, Lee CC, Lin YC, Lai CC, Tsai FJ,. 2011. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 412 (19-20): 1861-1866.
83. Huang YF, Chang HT,. 2007. Analysis of adenosine triphosphate and glutathione through gold nanoparticles assisted laser desorption/ionization mass spectrometry. Anal Chem 79 (13): 4852-4859.
84. Huang CY, Su CT, Chung CJ, Pu YS, Chu JS, Yang HY, Wu CC, Hsueh YM,. 2012. Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure. Toxicol Appl Pharmacol 262 (3): 349-354.
85. Hui Y, Zhao SS, Love JA, Ansley DM, Chen DD,. 2012. Development and application of a LC-MS/MS method to quantify basal adenosine concentration in human plasma from patients undergoing on-pump CABG surgery. J Chromatogr B Analyt Technol Biomed Life Sci 885-886: 30-36.
86. Iijima H, Patrzyc HB, Dawidzik JB, Budzinski EE, Cheng HC, Freund HG, Box HC,. 2004. Measurement of DNA adducts in cells exposed to cisplatin. Anal Biochem 333 (1): 65-71.
87. E analysis of RNA oligonucleotides. Rapid Commun Mass Spectrom 24: 2631-2640.
88. Izzi B, Decallonne B, Devriendt K, Bouillon R, Vanderschueren D, Levtchenko E, de Zegher F, Van den Bruel A, Lambrechts D, Van Geet C, Freson K,. 2010. A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system. Clin Chim Acta 411 (23-24): 2033-2039.
89. Jankowski J, Grosse-Hüttmann P, Zidek W, Schlüter H,. 2003. Identification of dinucleoside polyphosphates by matrix-assisted laser desorption/ionisation post-source decay mass spectrometry. Rapid Commun Mass Spectrom 17 (11): 1189-1194.
90. Jaruga P, Dizdaroglu M,. 2010. Identification and quantification of (5′R)- and (5′S)-8,5′-cyclo-2′-deoxyadenosines in human urine as putative biomarkers of oxidatively induced damage to DNA. Biochem Biophys Res Commun 397 (1): 48-52.
91. Jégourel D, Delépée R, Breton F, Rolland A, Vidal R, Agrofoglio LA,. 2008. Molecularly imprinted polymer of 5-methyluridine for solid-phase extraction of pyrimidine nucleoside cancer markers in urine. Bioorg Med Chem 16 (19): 8932-8939.
92. Jeng LB, Lo WY, Hsu WY, Lin WD, Lin CT, Lai CC, Tsai FJ,. 2009. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis. Rapid Commun Mass Spectrom 23 (11): 1543-1549.
93. Jensen SS, Ariza X, Nielsen P, Vilarrasa J, Kirpekar F,. 2007. Collision-induced dissociation of cytidine and its derivatives. J Mass Spectrom 42: 49-57.
94. Jöckel S, Nees G, Sommer R, Zhao Y, Cherkasov D, Hori H, Ehm G, Schnare M, Nain M, Kaufmann A, Bauer S,. 2012. The 2′-O-methylation status of a single guanosine controls transfer RNA-mediated Toll-like receptor 7 activation or inhibition. J Exp Med 209 (2): 235-241.
95. Kang W,. 2012. Quantitative determination of uridine in rabbit plasma and urine by liquid chromatography coupled to a tandem mass spectrometry. Biomed Chromatogr 26 (4): 541-544.
96. Kaur J, Raj M, Cooperman BS,. 2011. Fluorescent labelling of tRNA dihydrouridine residues: Mechanism and distribution. RNA 17: 1393-1400.
97. Klaene JJ, Sharma VK, Glick J, Vouros P,. 2012. The analysis of DNA adducts: The transition from (32)P-postlabeling to mass spectrometry. Cancer Lett doi: 10.1016/j.canlet.2012.08.007, PII: S0304-3835(12)00478.-8 [Epub ahead of print].
98. Koc H, Tretyakova NY, Walker VE, Henderson RF, Swenberg JA,. 1999. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to butadiene. Chem Res Toxicol 12: 566-574.
99. Koivisto P, Peltonen K,. 2010. Analytical methods in DNA and protein adduct analysis. Anal Bioanal Chem 398 (6): 2563-2572.
100. Kok RM, Smith DE, Barto R, Spijkerman AM, Teerlink T, Gellekink HJ, Jakobs C, Smulders YM,. 2007. Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: Analytical technique, reference values and determinants in healthy subjects. Clin Chem Lab Med 45: 903-911.
101. Koshida K, Harmenberg J, Borgström E, Wahren B, Andersson L,. 1985. Pseudouridine and uridine in normal kidney and kidney cancer tissues. Urol Res 13 (5): 219-221.
102. Kotandeniya D, Murphy D, Seneviratne U, Guza R, Pegg A, Kanugula S, Tretyakova N,. 2011. Mass spectrometry based approach to study the kinetics of O6-alkylguanine DNA alkyltransferase-mediated repair of O6-pyridyloxobutyl- 2′-deoxyguanosine adducts in DNA. Chem Res Toxicol 24 (11): 1966-1975.
103. Kowalak JA, Pomerantz SC, Crain PF, McCloskey JA,. 1993. A novel method for the determination of posttranscriptional modification in RNA by mass spectrometry. Nucleic Acids Res 21: 4577-4585.
104. LYS (UUU) from Trypanosoma brucei. FEBS J 278: 4782-4796.
105. Kvist E, Sjølin KE, Iversen J, Nyholm K,. 1993. Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder. Scand J Urol Nephrol 27 (1): 45-53.
106. Lai Y, Lu M, Lin S, Wu H, Cai Z,. 2011. Electrospray ionisation tandem mass spectrometric characterisation of DNA adducts formed by bromobenzoquinones. Rapid Commun Mass Spectrom 25 (19): 2943-2950.
107. Langridge JI, McClure TD, el-Shakawi S, Fielding A, Schram KH, Newton RP,. 1993. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers. Rapid Commun Mass Spectrom 7 (6): 427-434.
108. Leclercq L, Laurent C, De Pauw E,. 1997. High-performance liquid chromatography/electrospray mass spectrometry for the analysis of modified bases in DNA: 7-(2-hydroxyethyl)guanine, the major ethylene oxide-DNA adduct. Anal Chem 69: 1952-1955.
109. Lee SH, Jung BH, Kim SY, Chung BC,. 2004. A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun Mass Spectrom 18 (9): 973-977.
110. Lee SH, Kim I, Chung BC,. 2007. Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease. Clin Biochem 40 (13-14): 936-938.
111. Li X, Franke AA,. 2011. High-throughput and cost-effective global DNA methylation assay by liquid chromatography-mass spectrometry. Anal Chim Acta 703 (1): 58-63.
112. Li HY, Wang SM, Liu HM, Li J, Han D, Bu SS, Zhang MZ,. 2008. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 22 (20): 3161-3171.
113. Li HY, Wang SM, Liu HM, Bu SS, Li J, Han D, Zhang MZ, Wu GY,. 2009. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom 44 (5): 641-651.
114. Liebich HM, Müller-Hagedorn S, Bacher M, Scheel-Walter HG, Lu X, Frickenschmidt A, Kammerer B, Kim KR, Gérard H,. 2005a. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 814 (2): 275-283.
115. Liebich HM, Müller-Hagedorn S, Klaus F, Meziane K, Kim KR, Frickenschmidt A, Kammerer B,. 2005b. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers. J Chromatogr A 1071 (1-2): 271-275.
116. Liguori A, Napoli A, Sindona G,. 2000. Survey of the proton affinities of adenine, cytosine, thymine and uracil dideoxyribonucleosides, deoxyribonucleosides and ribonucleosides. J Mass Spectrom 35: 139-144.
117. Lijinsky W, Loo J, Ross AE,. 1968. Mechanism of alkylation of nucleic acids by nitrosodimethylamine. Nature 218: 1174-1175.
118. Limbach PA, Crain PF, McCloskey JA,. 1994. Summary: The modified nucleosides of RNA. Nucleic Acids Res 22: 2183.
119. Liu P, Li YY, Li HM, Wan DJ, Tang YJ,. 2011. Determination of the nucleosides and nucleobases in Tuber samples by dispersive solid-phase extraction combined with liquid chromatography-mass spectrometry. Anal Chim Acta 687 (2): 159-1167.
120. Lu M, Lai Y, Chen G, Cai Z,. 2011. Matrix interference-free method for the analysis of small molecules by using negative ion laser desorption/ ionization on graphene flakes. Anal Chem 83 (8): 3161-3169.
121. Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT, Gorelik E, Lang S, Whiteside TL,. 2010. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J Biol Chem 285 (36): 27571-27580.
122. Martinow AJ, Yuen K, Cooper IA, Matthews JP, Juneja S, Wolf M, Januszewicz H, Prince HM,. 1998. Prognostic markers of disease activity in Hodgkin's disease. Leuk Lymphoma 29 (3-4): 383-389.
123. McCloskey JA,. 1990a. Constituents of nucleic acids: Overview and strategy. In:, McCloskey JA, editor. Methods in enzymology. Vol. 193. New York, CA: Academic Press, Inc. pp. 771-781.
124. McCloskey JA,. 1990b. Electron ionization mass spectra of trimethylsilyl derivatives of nucleosides. In:, McCloskey JA, editor. Methods in enzymology. Vol. 193. New York: Elsevier. pp. 825-842.
125. McEntire KD, Mowery J, Hixson DC,. 1989. Comparison of the structural characteristics of cell-CAM 105 from hepatocytes with those of an altered form expressed by rat transplantable hepatocellular carcinomas. Cancer Res 49 (23): 6795-6802.
126. Nair U, Bartsch H, Nair J,. 2007. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: A review of published adduct types and levels in humans. Free Radic Biol Med 43 (8): 1109-1120.
127. Nakano K, Nakao T, Schram KH, Hammargren WM, McClure TD, Katz M, Petersen E,. 1993. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Clin Chim Acta 218 (2): 169-183.
128. Nelson CC, McCloskey JA,. 1992. Collision-induced dissociation of adenine. J Am Chem Soc 114 (10): 3661-3668.
129. Nelson CC, McCloskey JA,. 1994. Collision-induced dissociation of uracil and its derivatives. J Am Soc Mass Spectrom 5 (5): 339-349.
130. Neubauer S, Rugova A, Chu DB, Drexler H, Ganner A, Sauer M, Mattanovich D, Hann S, Koellensperger G,. 2012. Mass spectrometry based analysis of nucleotides, nucleosides, and nucleobases-application to feed supplements. Anal Bioanal Chem 404 (3): 799-808.
131. Newton RP,. 2009. Mass spectrometric application in the study of cyclic nucleotides in biochemical signal transduction. In:, Banoub JH, Limbach PA, editors. Mass spectrometry of nucleosides and nucleic acids. Florida: CRC Press. pp. 127-162.
132. Niwa T,. 1997. Mass spectrometry in the search for uremic toxins. Mass Spectrom Rev 16 (6): 307-332.
133. Noma A, Sakaguchi Y, Suzuki T,. 2009. Mechanistic characterization of the sulfur-relay system for eukaryotic 2-thiouridine biogenesis at tRNA wobble positions. Nucleic Acids Res 37: 1335-1352.
134. Olsen R, Ovrebo S, Thorud S, Lundanes E, Thomassen Y, Greibrokk T, Molander P,. 2008. Sensitive determination of a glyoxal-DNA adduct biomarker candidate by column switching capillary liquid chromatography electrospray ionisation mass spectrometry. Analyst 133: 802-809.
135. Pathak C, Jaiswal YK, Vinayak M,. 2008. Queuine mediated inhibition in phosphorylation of tyrosine phosphoproteins in cancer. Mol Biol Rep 35 (3): 369-374.
136. Patil A, Chan CT, Dyavaiah M, Rooney JP, Dedon PC, Begley TJ,. 2012. Translational infidelity-induced protein stress results from a deficiency in Trm9-catalyzed tRNA modifications. RNA Biol 9 (7): 990-1001.
137. Patrzyc HB, Dawidzik JB, Budzinski EE, Iijima H, Box HC,. 2001. Double lesions are produced in DNA oligomer by ionizing radiation and by metal-catalyzed H2O2 reactions. Radiat Res 155 (4): 634-636.
138. Pearson D, Hienzsch A, Wagner M, Globisch D, Reiter V, Ozden D, Carell T,. 2011. LC-MS based quantification of 2′-ribosylated nucleosides Ar(p) and Gr(p) in tRNA. Chem Commun 47: 5196-5198.
139. Plattner S, Erb F, Brouwer HJ, Oberacher H,. 2012. Formation and characterisation of covalent guansoine adducts with electrochemistry-liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 883 (4): 198-204.
140. Pomerantz SC, McCloskey JA,. 1990. Analysis of RNA hydrolyzates by liquid chromatography-mass spectrometry. In:, McCloskey JA, editor. Nucleic acid constituents. Methods in enzymology. Vol. 193. New York, CA: Academic Press, Inc. pp. 796-824.
141. Pucci V, Giuliano C, Zhang R, Koeplinger KA, Leone JF, Monteagudo E, Bonelli F,. 2009. HILIC LC-MS for the determination of 2′-C-methyl- cytidine-triphosphate in rat liver. J Sep Sci 32 (9): 1275-1283.
142. Rahman KM, James CH, Bui TT, Drake AF, Thurston DE,. 2011. Observation of a single-stranded DNA/pyrrolobenzodiazepine adduct. J Am Chem Soc 133 (48): 19376-19385.
143. Rahman KN, James CH, Thurston DE,. 2011. Observation of the reversibility of a covalent pyrrolobenzodiazepine (PBD) DNA adduct by HPLC/MS and CD spectroscopy. Org Biomol Chem 9 (5): 1632-1641.
144. Randall KL, Argoti D, Paonessa JD, Ding Y, Oaks Z, Zhang Y, Vouros P,. 2010. An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues. J Chromatogr A 1217: 4135-4143.
145. Rappaport SM, Li H, Grigoryan H, Funk WE, Williams ER,. 2012. Adductomics: Characterizing exposures to reactive electrophiles. Toxicol Lett 213 (1): 83-90.
146. Rasmuson T, Björk GR,. 1995. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma. Acta Oncol 34 (1): 61-67.
147. Rodríguez-Gonzalo E, García-Gõmez D, Carabias-Martínez R,. 2011a. Study of retention behaviour and mass spectrometry compatibility in zwitterionic hydrophilic interaction chromatography for the separation of modified nucleosides and nucleobases. J Chromatogr A 1218 (26): 3994-4001.
148. Rodríguez-Gonzalo E, García-Gõmez D, Carabias-Martínez R,. 2011b. Development and validation of a hydrophilic interaction chromatography-tandem mass spectrometry method with on-line polar extraction for the analysis of urinary nucleosides. Potential application in clinical diagnosis. J Chromatogr A 1218 (50): 9055-9063.
149. Rojsitthisak P, Jongaroonngamsang N, Romero RM, Haworth IS,. 2011. HPLC-UV, MALDI-TOF-MS and ESI-MS/MS analysis of the mecholroethamine DNA crossline at cytosine-cytosine mismatch pair. PLoS ONE 6: e20745.
150. Roszkowski K, Gackowski D, Rozalski R, Dziaman T, Siomek A, Guz J, Szpila A, Foksinski M, Olinski R,. 2008. Small field radiotherapy of head and neck cancer patients is responsible for oxidatively damaged DNA/oxidative stress on the level of a whole organism. Int J Cancer 123 (8): 1964-1967.
151. Rozenski J,. 2011. Analysis of nucleosides using the atmospheric-pressure solids analysis probe for ionization. Int J Mass Spec 304 (2-3): 204-208.
152. Sabunciyan S, Aryee MJ, Irizarry RA, Rongione M, Webster MJ, Kaufman WE, Murakami P, Lessard A, Yolken RH, Feinberg AP, Potash JB, GenRED Consortium. 2012. Genome-wide DNA methylation scan in major depressive disorder. PLoS ONE 7 (4): e34451.
153. Sagoo S, Beach DG, Manderville RA, Gabryelski W,. 2011. Tautomerisation in gas-phase ion chemistry of isomeric C-8 deoxyguanosine adducts from phenol-induced DNA damage. J Mass Spectrom 46: 41-49.
154. Sangaraju D, Goggin M, Walker V, Swenberg J, Trtyakova N,. 2012. NanoHPLC-nanoESI(+)-MS/MS quantitation of bis-N7-guanine DNA-DNA cross-links in tissues of B6C3F1 mice exposed to subppm levels of 1,3-butadiene. Anal Chem 84: 1732-1739.
155. Sasco AJ, Rey F, Reynaud C, Bobin JY, Clavel M, Niveleau A,. 1996. Breast cancer prognostic significance of some modified urinary nucleosides. Cancer Lett 108 (2): 157-162.
156. Schram KH,. 1990. Preparation of trimethylsilyl derivatives of nucleic acid components for analysis by mass spectrometry. In:, McCloskey JA, editor. Nucleic acid constituents. Methods in enzymology. Vol. 193. New York, CA: Academic Press, Inc. pp. 791-796.
157. Schram KH,. 1998. Urinary nucleosides. Mass Spectrom Rev 17 (3): 131-251.
158. Scorrano S, Longo L, Vasapollo G,. 2009. Molecularly imprinted polymers for solid-phase extraction of 1-methyladenosine from human urine. Anal Chim Acta 659 (1-2): 167-171.
159. Sharma VK, Glick J, Liao Q, Shen C, Vouros P,. 2012a. GenoMass software: A tool based on electrospray ionization tandem mass spectrometry for characterization and sequencing of oligonucleotide adducts. J Mass Spectrom 47 (4): 490-501.
160. Sharma K, Singh R, Giri S, Rajagopal S, Mullangi R,. 2012b. Highly sensitive method for the determination of adenosine by LC-MS/MS-ESI: Method validation and scope of application to a pharmacokinetic/pharmacodynamic study. Biomed Chromatogr 26 (1): 81-88.
161. Sheltar MD, Chung J,. 2012. The cyclobutane dimmers of 2′-deoxyuridine, 2′-deoxycytidine, 5-methyl-2′-deoxycytidine and 5-bromo-2′-deoxyuridne. Photochem Photobiol 88: 1236-1247.
162. Shen J, Wang S, Zhang YJ, Wu HC, Kibriya MG, Jasmine F, Ahsan H, Wu DP, Siegel AB, Remotti H, Santella RM,. 2012. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics 8 (1): 34-43.
163. Shetlar MD, Chung J,. 2011. Opened-ring adducts of 5-methylcytosine and 1,5-dimethylcytosine with amines and water and evidence for an opened-ring hydrate of 2′-deoxycytidine. Photochem Photobiol 87: 818-832.
164. Shetlar MD, Chung J,. 2012. The cyclobutane dimers of 2'-deoxyuridine, 2'-deoxycytidine, 5-methyl-2'-deoxycytidine and 5-bromo-2'-deoxyuridine. Photochem Photobiol 88 (5): 1236-1247.
165. Silvestri C, Brodbelt JS,. 2013. Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics. Mass Spectrom Rev 32 (4): 247-266.
166. Singh R, Teichert F, Verschoyle RD, Kaur B, Vives M, Sharma RA, Steward WP, Gescher AJ, Farmer PB,. 2009. Simultaneous determination of 8-oxo-2′-deoxyguanosine and 8-oxo-2′-deoxyadenosine in DNA using online column-switching liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 23: 151-160.
167. Singh R, Arlt VM, Hendreson CJ, Phillips DH, Farmer PB, Gamboa da Costa G,. 2010a. Detection and quantitation of N-(deoxyguanosin-8-yl)-2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine adducts in DNA using online column-switching liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878: 2155-2162.
168. Singh R, Teichert F, Seidel A, Roach J, Cordell R, Cheng MK, Frank H, Steward WP, Manson MM, Farmer PB,. 2010b. Development of a targeted adductomic method for the determination of polycyclic aromatic hydrocardon DNA adducts using online column-switching liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 24: 2329-2340.
169. Slowikowski DL, Schram KH,. 1985. Fast atom bombardment mass spectra of nucleosides. Comparison with electron impact and chemical ionisation mass spectra. Nucleosides Nucleotides 4: 347-376.
170. Smith SI, Brodbelt JS,. 2011. Hybrid activation methods for elucidating nucleic acid modifications. Anal Chem 83: 303-310.
171. Spilsberg B, Rundberget T, Johannessen LE, Kristoffersen AB, Holst-Jensen A, Berdal KG,. 2010. Detection of food-derived damaged nucleosides with possible adverse effects on human health using a global adductomics approach. J Agric Food Chem 58: 6370-6375.
172. Sprinzl M, Hartmann J, Weber J, Blank J, Zeidler R,. 1989. Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res 17: r1-172.
173. Szymańska E, Markuszewski MJ, Markuszewski M, Kaliszan R,. 2010. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis. J Pharm Biomed Anal 53 (5): 1305-1312.
174. Tang Y, Gao XD, Wang Y, Yuan BF, Feng YQ,. 2012. Widespread existence of cytosine methylation in yeast DNA measured by gas chromatography/mass spectrometry. Anal Chem 84 (16): 7249-7255.
175. Teichert F, Winkler S, Keun HC, Steward WP, Gescher AJ, Farmer PB, Singh R,. 2011. Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 25 (14): 2071-2082.
176. Tomikawa C, Yokogawa T, Kanai T, Hori H,. 2010. N7-Methylguanine at position 46 (m7G46) in tRNA from Thermus thermophilus is required for cell viability at high temperatures through a tRNA modification network. Nucleic Acids Res 38 (3): 942-957.
177. Tost J, Schatz P, Schuster M, Berlin K, Gut IG,. 2003. Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res 31: e50.
178. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T,. 1997. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76 (3): 365-374.
179. Tretyakova NY, Chiang SY, Walker VE, Swenberg JA,. 1998. Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry. J Mass Spectrom 33: 363-376.
180. Tretyakova N, Goggin M, Sangaraju D, Janis G,. 2012. Quantitation of DNA adducts by stable isotope dilution mass spectrometry. Chem Res Toxicol 25 (10): 2007-2035.
181. 2O adduct formation and gas-phase reactions in the collision cell. J Am Soc Mass Spectrom 16 (8): 1291-1304.
182. Tuytten R, Lemière F, Esmans EL, Herrebout WA, van der Veken BJ, Dudley E, Newton RP, Witters E,. 2006. In-source CID of guanosine: Gas phase ion-molecule reactions. J Am Soc Mass Spectrom 17 (8): 1050-1062.
183. Tuytten R, Lemière F, Esmans EL, Herrebout WA, van der Veken BJ, Maes BU, Witters E, Newton RP, Dudley E,. 2007. Role of nitrogen lewis basicity in boronate affinity chromatography of nucleosides. Anal Chem 79 (17): 6662-6669.
184. Tuytten R, Lemière F, Van Dongen W, Witters E, Esmans EL, Newton RP, Dudley E,. 2008. Development of an on-line SPE-LC-ESI-MS method for urinary nucleosides: Hyphenation of aprotic boronic acid chromatography with hydrophilic interaction LC-ESI-MS. Anal Chem 80 (4): 1263-1271.
185. Tyburski JB, Patterson AD, Krausz KW, Slavík J, Fornace AJ, Jr., Gonzalez FJ, Idle JR,. 2009. Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res 172 (1): 42-57.
186. Urakami K, Zangiacomi V, Yamaguchi K, Kusuhara M,. 2010. Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed Res 31 (2): 161-163.
187. Van Dycke A, Verstraete A, Pil K, Raedt R, Vonck K, Boison D, Boon P,. 2010. Quantitative analysis of adenosine using liquid chromatography/atmospheric pressure chemical ionization-tandem mass spectrometry (LC/APCI-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci 878 (19): 1493-1498.
188. Vanden Bussche J, Moore SA, Pasmans F, Kuhnle GG, Vanhaecke L,. 2012. An approach based on ultra-high pressure liquid chromatography-tandem mass spectrometry to quantify O6-methyl and O6-carboxymethykguanine DNA adducts in intestinal cell lines. J Chromatogr A 1257: 25-33.
189. Von Minden DL, McCloskey JA,. 1973. Mass spectrometry of nucleic acid components. N,O-Permethyl derivatives of nucleosides. J Am Chem Soc 95: 7480-7490.
190. Wang S, Zhao X, Mao Y, Cheng Y,. 2007. Novel approach for developing urinary nucleosides profile by capillary electrophoresis-mass spectrometry. J Chromatogr A 1147 (2): 254-260.
191. Wang X, Suo Y, Yin R, Shen H, Wang H,. 2011. Ultra-performance liquid chromatography/tandem mass spectrometry for accurate quantification of global DNA methylation in human sperms. J Chromatogr B Analyt Technol Biomed Life Sci 879 (19): 1647-1652.
192. Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H III, Lovell MA, Murphy MP,. 2012. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease. Carcinogenesis 33: 124-130.
193. Wetzel C, Limbach PA,. 2012. Global identification of transfer RNAs by liquid chromatography-mass spectrometry (LC-MS). J Proteomics 75: 3450-3464.
194. Williams JP, Lough JA, Campuzano I, Richardson K, Sadler PJ,. 2009. Use of ion mobility mass spectrometry and a collision cross-section algorithm to study an organometallic ruthenium anticancer complex and its adducts with a DNA oligonucleotide. Rapid Commun Mass Spectrom 23: 3563-3569.
195. Wrobel K, Flores CR, Chan Q, Wrobel K,. 2010. Ribonucleoside labelling with Os (VI): A methodological approach to evaluation of RNA methylation by HPLC-ICP-MS. Metallomics 2: 140-146.
196. Wu KY, Chiang SY, Shih WC, Huang CC, Chen MF, Swenberg JA,. 2011. The application of mass spectrometry in molecular dosimetry: Ethylene oxide as an example. Mass Spectrom Rev doi: 10.1002/mas.20299 [Epub ahead of print].
197. Xia JF, Hu P, Liang QL, Zou TT, Wang YM, Luo GA,. 2010. Correlations of creatine and six related pyrimidine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients. Clin Biochem 43 (12): 957-962.
198. Xia JF, Wang ZH, Liang QL, Wang YM, Li P, Luo GA,. 2011. Correlations of six related pyrimidine metabolites and diabetic retinopathy in Chinese type 2 diabetic patients. Clin Chim Acta 412 (11-12): 940-945.
199. Xu G, Schmid HR, Lu X, Liebich HM, Lu P,. 2000. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Biomed Chromatogr 14 (7): 459-463.
200. Yamaoka N, Kaneko K, Kudo Y, Aoki M, Yasuda M, Mawatari K, Nakagomi K, Yamada Y, Yamamoto T,. 2010a. Analysis of purine in purine-rich cauliflower. Nucleosides Nucleotides Nucleic Acids 29 (4-6): 518-521.
201. Yamaoka N, Kudo Y, Inazawa K, Inagawa S, Yasuda M, Mawatari K, Nakagomi K, Kaneko K,. 2010b. Simultaneous determination of nucleosides and nucleotides in dietary foods and beverages using ion-pairing liquid chromatography- electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878 (23): 2054-2060.
202. Yamaoka N, Inazawa K, Inagawa S, Yasuda M, Mawatari K, Nakagomi K, Fujimori S, Yamada Y, Kaneko K,. 2011. Simultaneous determination of purine and pyrimidine metabolites in HPRT-deficient cell lines. Nucleosides Nucleotides Nucleic Acids 30 (12): 1256-1259.
203. Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S, Yang Q,. 2004. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B 813 (1-2): 59-65.
204. Yang FQ, Ge L, Yong JW, Tan SN, Li SP,. 2009. Determination of nucleosides and nucleobases in different species of Cordyceps by capillary electrophoresis-mass spectrometry. J Pharm Biomed Anal 50 (3): 307-314.
205. Yang FQ, Li DQ, Feng K, Hu DJ, Li SP,. 2010. Determination of nucleotides, nucleosides and their transformation products in Cordyceps by ion-pairing reversed-phase liquid chromatography-mass spectrometry. J Chromatogr A 1217 (34): 5501-5510.
206. Yang I, Fortin MC, Richardson JR, Buckley B,. 2011. Fused-core silica column ultra-performance liquid chromatography-ion trap tandem mass spectrometry for determination of global DNA methylation status. Anal Biochem 409 (1): 138-143.
207. Yang BT, Dayeh TA, Volkov PA, Kirkpatrick CL, Malmgren S, Jing X, Renström E, Wollheim CB, Nitert MD, Ling C,. 2012. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol 26 (7): 1203-1212.
208. Yen-Yang Y, Charles MJ, Voyksner RD,. 1996. Processes that affect electrospray ionization-mass spectrometry of nucleobases and nucleosides. J Am Soc Mass Spectrom 7: 1106-1108.
209. Zayed A, Jones GD, Reid HJ, Shoeib T, Taylor SE, Thomas AL, Wood JP, Sharp BL,. 2011. Speciation of oxaliplatin adducts with DNA nucleotides. Metallomics 3: 991-1000.
210. Zhang JJ, Zhang L, Zhou K, Ye X, Liu C, Zhang L, Kang J, Cai C,. 2011a. Analysis of global DNA methylation by hydrophilic interaction ultra high-pressure liquid chromatography tandem mass spectrometry. Anal Biochem 413 (2): 164-170.
211. Zhang SM, Chen KM, Aliaga C, Sun YW, Lin JM, Sharma AK, Amin S, El-Bayoumy K,. 2011b. Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS. Chem Res Toxicol 24: 1297-1303.
212. Zhao C, Yin R, Yin J, Zhang D, Wang H,. 2012. Capillary monolithic bioreactor of immobilized snake venom phosphodiesterase for mass spectrometry based oligodeoxynucleotide sequencing. Anal Chem 84: 1157-1164.
213. Zheng YF, Kong HW, Xiong JH, Lv S, Xu GW,. 2005. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Clin Biochem 38 (1): 24-30.
214. Zhu P, Lee SH, Wehrli S, Blair IA,. 2006. Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells. Chem Res Toxicol 19 (6): 809-817.